Diabetes pill shows Real-World promise for blood sugar and weight
NCT ID NCT04537637
Summary
This study observed 99 adults with type 2 diabetes in Denmark who were prescribed the once-daily pill Rybelsus® (oral semaglutide) by their doctor. The goal was to see how well the medication worked in everyday life to lower blood sugar and body weight over 8-10 months. Researchers collected information through doctor visits and patient questionnaires to understand the treatment's real-world effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Master Centre for Denmark
Copenhagen S, 2300, Denmark
-
Novo Nordisk investigational site
Søborg, 2860, Denmark
Conditions
Explore the condition pages connected to this study.